Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of the study is to evaluate how limiting the nicotine content in regular cigarettes affects choices for regular cigarette and e-cigarette products. Eligible participants will be of legal age to purchase tobacco products and regularly use both e-cigarettes and regular cigarettes.
Full description
Participants in this study will undergo an in-person screening session where the study will be explained in detail and participants will answer questions and provide a breath sample. During the screening session, participants will also be asked to complete surveys. Eligible participants will then complete the training procedures during which they will select an e-cigarette device to use for future preference sessions. During the 4 preference sessions, participants will sample puffs from an e-cigarette and regular cigarette and answer questions about their experience with each. They will also complete a task during which they can choose to earn puffs from the e-cigarette or regular cigarette, or choose to not take any puffs. The 4 sessions will be the same except that a different combination of e-cigarette and regular cigarette is used at each session.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Unstable medical conditions as determined by the licensed medical professional;
Unstable psychiatric conditions as determined by the licensed medical professional or PI;
Currently pregnant, breastfeeding, trying to become pregnant or unwilling to agree to use adequate protection to avoid pregnancy;
Serious quit attempt of either or both products in the past 3 months resulting in >30 days of abstinence;
Currently using nicotine replacement therapy or other pharmacotherapies as cessation aide;
Plans to quit use of either EC or CC, or all tobacco products in the next 45 days;
Self-reporting nicotine-free, CBD, or THC liquid is preferred or usual e-liquid;
Vital signs outside of the following range (participants failing for vital signs will be allowed to re-screen once):
Allergy to propylene glycol or vegetable glycerin;
Previous adverse reaction when using vaping device or e-liquid;
Current or recent alcohol or drug abuse problems;
Previous use of SPECTRUM or other reduced nicotine content cigarettes in past 3 months;
Literate and able to independently complete and comprehend the consent form and other written study materials and measures.
Primary purpose
Allocation
Interventional model
Masking
7 participants in 4 patient groups
Loading...
Central trial contact
Rachel Kozink; Alicia Holloway
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal